1 / 7

Diabetes Drug Market Outlook

Global diabetes drug market is expected to surpass US$ 76 Billion by 2024. Renub Research report titled “Diabetes Drug Market, Oral (DPP IV Inhibitor, SGLT-2, Alpha Glucosidase Inhibitor, Biguanide) Injection (Glucagon-like peptide (GLP) 1 agonist, Amylin Receptor Agonist), Insulin (Rapid – Acting Insulin, Long Acting Insulin, Premixed Insulin), Regions (United States, Europe, Japan, China, India, Brazil), Companies (Novo Nordisk, Merck & Co, Eli Lilly, AstraZeneca, Johnson & Johnson, Boehringer Ingelheim)” provides Diabetes Drug Market. <br>Access full Research: <br>https://www.renub.com/diabetes-drug-market-p.php

renubresearch
Download Presentation

Diabetes Drug Market Outlook

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Diabetes Drug Market

  2. Report Description and Highlights Analyst View: Global diabetes drug market is expected to surpass US$ 76 Billion by the end of year 2024. Rising global diabetes prevalence like Type 1 diabetes and Type 2 diabetes is the major reason for growth of diabetes drug market. Type 2 diabetes is on the rise globally due to growth in obesity trends, sedentary lifestyle and lack of physical activity. Type1 diabetes patient requires less amount diabetes drug, whereas Type 2 diabetes patient are massive consumer of diabetes drug. Renub Research report titled “Diabetes Drug Market, Oral (DPP IV Inhibitor, SGLT-2, Alpha Glucosidase Inhibitor, Biguanide) Injection (Glucagon-like peptide (GLP) 1 agonist, Amylin Receptor Agonist), Insulin (Rapid – Acting Insulin, Long Acting Insulin, Premixed Insulin), Regions (United States, Europe, Japan, China, India, Brazil) & Companies” provides a complete analysis of Diabetes Drug Market. Read more here: https://www.renub.com/diabetes-drug-market-p.php

  3. (DPP) IV Inhibitor Segment has the largest Market in Global Diabetes Drug Market • According to Renub Research this report provides in-depth analysis of diabetes drug market form multiple perspectives. Here the global diabetes drug market has been categorized into 3 segments: Oral Diabetes Drug Market, Injectable Diabetes Drug Market and Insulin. • Oral Diabetes Drug Market is further sub-divided into 5 categories by drug class- (DPP) IV Inhibitor, SGLT-2, Alpha Glucosidase Inhibitor, Biguanide and Other Oral Drug market. • Injectable Diabetes Drug Market has been further classified into 2 parts - Glucagon-like peptide (GLP) 1 agonist and Amylin receptor agonist market. • Insulin Market has been further categorized into 4 parts - Rapid – Acting Insulin market, Long Acting Insulin market, Premixed Insulin market and Other Insulin market.

  4. Global Forecast for Diabetes Drug Market Share Global Forecast for Diabetes Drug Market Share by Oral Drug (%), 2018 - 2024 Source: Renub Research Analysis Note: These are dummy figures; actual data given in the report

  5. United States dominates the Global diabetes drug Market The regions covered in the report for of type 1 diabetes drug market are United States, European Union (France, Germany, Italy, Spain and United Kingdom), Japan and Canada.  The regions covered for type 2 diabetes drug market - are United States, European Union (France, Germany, Italy, Spain and United Kingdom), Japan, China, India and Brazil. In addition, we have also covered diabetes population of each of these covered regions along with Type 1 and Type 2 diabetes populations. Novo Nordisk is the Largest Player in Global Diabetes Drug Market In this report, published by Renub Research a comprehensive assessment of global diabetes drug revenue by five major key players is covered. The key players covered in the report are Novo Nordisk, Merck & Co, Eli Lilly, AstraZeneca, Johnson & Johnson and BoehringerIngelheim. Want more Information about this market? Request a free sample copy: https://www.renub.com/contactus.php

  6. Global Forecast for Diabetes Drug Market Share Global Forecast for Diabetes Drug Market Share by Regions - Type 2 (%), 2018 - 2024 Source: Renub Research Analysis Note: These are dummy figures; actual data given in the report Source: Renub Research Analysis Note: These are dummy figures; actual data given in the report

  7. Key Players covered in this report • Key Players Analysis • 1.    Novo Nordisk2.    Merck & Co3.    Eli Lilly4.    AstraZeneca5.    Johnson & Johnson6.BoehringerIngelheim • Browse Related Report : • Global CGM Market • Insulin Pump Market • Contact Us • Rajat Gupta • Tel: +1-678-302-0700 • Email: info@renub.com

More Related